Search for: "Sanofi-Aventis US Inc" Results 81 - 100 of 160
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
3 Nov 2010, 7:00 am
("Amphastar") sued FDA over FDA's decision to detain imported raw material used to make a generic form of Lovenox® (enoxaparin sodium), the blockbuster, heparin-based blood thinner sold by Sanofi-Aventis SA. [read post]
15 Oct 2010, 7:49 am by Keith Lee
It’s just how Sanofi-aventis, Proctor and Gamble and Citibank stay competitive!! [read post]
31 Aug 2010, 10:01 pm by Kelly
Apotex Inc. et al (Docket Report) Lovenox (Enoxaparin) – US: DC District Court denies preliminary injunction in generic Lovenox case; Is the juice worth the squeeze for Sanofi to appeal? [read post]
20 Aug 2010, 4:47 am by Varun Chhonkar
Judge Gregory Sleet of the US District Court for the District of Delaware lately decided in favor of Sanofi-Aventis in Uroxatral patent lawsuit and ruled that Sanofi’s US Patent Number 4,661,491 is valid and infringed by generic alfuzosin versions from Aurobindo Pharma and Torrent Pharma Inc. [read post]
5 Aug 2010, 2:08 pm by Bexis
Wyeth Laboratories, Inc., 533 N.E.2d 748 (Ohio 1988) (the Ohio Supreme Court rejecting the theory). [read post]
25 Jun 2010, 1:28 pm by Tom Lamb
We start with a June 24, 2010 Wall Street Journal article, "WellPoint's Data Led It To Limit Use Of Drug Boniva Article", from we learn that the largest U.S. managed care business in terms of membership, WellPoint Inc., has found through internal research that the osteoporosis drug Boniva, which is marketed by Roche Holding AG's Genentech and GlaxoSmithKline PLC, is linked to higher fracture rates than two other bisphosphonates, Actonel, marketed by… [read post]
23 Jun 2010, 10:28 pm
Patent and Trademark Office (Patent Docs) (Patentology) US: BIO celebrates anniversary of Chakrabarty decision (Patent Docs)   Products Allegra (Fexofenadine) – US: Sanofi-Aventis secures injunction against Dr. [read post]
16 Jun 2010, 3:02 pm
(Patent Docs) US: District Court M D North Carolina: $4.8 million attorneys’ fee award designed to reimburse not punish: Aventis CropScience v. [read post]
16 Jun 2010, 2:04 am by gmlevine
Pharmaceuticals (Sanofi-Aventis), banks and finance (Citigroup, Inc., MasterCard International Incorporated) , fashion (Christian Dior Couture), retail (Harrods Limited, Burberry Limited), hotels and travel (Sheraton International Inc.), automobiles (Bayerische Motoren Werke AG (BMW AG)) and toy manufacturers (LEGO Juris A/S) are frequent targets. [read post]
10 Jun 2010, 3:58 am
Kappos (Patent Docs)   Products Allegra (Fexofenadine) - US: Patent infringement complaint following a Paragraph IV certification: Sanofi-Aventis U.S. [read post]
3 Jun 2010, 5:35 am
– In re Ciprofloxacin Antitrust Litigation (PatLit) Circumvent PCV and Porcilis PCV vaccines – US: Wyeth files patent infringement suit against Intervet based on their manufacture of PCV vaccines (Patent Docs) Copegus (Ribavirin) – US: Ascio seeks declaratory judgment of unenforceability, invalidity and non-infringement of Three Rivers’ patent based on ANDA filing (Patent Docs) Entocort (Budesonide) – US: AstraZeneca settles Entocort patent… [read post]
21 May 2010, 2:32 am by gmlevine
Two recent examples of disclaimers bolstering bad faith are Sanofi-Aventis, Aventis Pharma SA, Aventis Pharmaceuticals Inc. v. [read post]